nevirapine XR

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

HIV Infections

Phase 3

VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients

CompletedNCT00561925

Boehringer IngelheimHIV Infections

Start: 2007-11-30Updated: 2014-04-07

Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients

CompletedNCT00819052

Boehringer IngelheimHIV Infections

Start: 2008-12-31End: 2012-01-31Updated: 2014-11-10

Related Papers

Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients.

2011-01-0143 citations